HCP Education - Teva supports healthcare professionals, patients, and caregivers through independent education to strengthen clinical decisions and improve health behaviors or health status.
Patient Education - Teva supports organizations that educate people with Huntington’s disease, tardive dyskinesia, or schizophrenia and their caregivers to improve understanding of symptoms, management, and treatment.
Huntington’s Disease - HCP supports healthcare professionals through independent medical education on diagnosis, treatment, and multidisciplinary care to strengthen Huntington’s disease management.
Biosimilars – HCP supports healthcare professionals through independent education on biosimilar concepts, approval, and treatment options to strengthen their knowledge and confidence in biosimilar use.
Tardive Dyskinesia - HCP supports healthcare professionals through independent medical education to improve recognition, diagnosis, assessment, and management of TD, including VMAT2 inhibitor use.